Skip to content

Clinical trials

Phase 4 Insulin Resistance trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Phase: Phase 4 Country / region: South Korea Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20093
20102
20116
20121
20141
20151
20171
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gachon University Gil Medical Center10
Eli Lilly and Company2
Seoul National University Bundang Hospital2
Seoul National University Hospital2
Chonbuk National University Hospital1
Samsung Medical Center1
Yonsei University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance19
Diabetes Mellitus6
Hypercholesterolemia5
Hypertriglyceridemia4
Diabetes Mellitus, Type 23
Hyperglycemia2
Hypertension2
Metabolic Diseases2
Prediabetic State2
Hypersensitivity1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.